We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.66B
2
HCA icon
HCA Healthcare
HCA
+$1.02B
3
BNY
Bank of New York Mellon
BNY
+$949M
4
AMT icon
American Tower
AMT
+$931M
5
FRC
First Republic Bank
FRC
+$890M

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMC
2426
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$186K ﹤0.01%
1,874
– –
DALN
2427
DELISTED
DallasNews
DALN
$184K ﹤0.01%
9,597
-4,169
-30% -$79.2K
LAND
2428
Gladstone Land Corp
LAND
$356M
$184K ﹤0.01%
13,700
– –
PRMW
2429
DELISTED
Primo Water Corporation
PRMW
$183K ﹤0.01%
+14,581
New +$175K
GPRE icon
2430
Green Plains
GPRE
$1.06B
$182K ﹤0.01%
10,800
-18,300
-63% -$322K
ALTO icon
2431
Alto Ingredients
ALTO
$320M
$181K ﹤0.01%
39,800
+19,700
+98% +$93.4K
CIO
2432
DELISTED
City Office REIT
CIO
$179K ﹤0.01%
13,774
+3,000
+28% +$39.3K
PHH
2433
DELISTED
PHH Corporation
PHH
$179K ﹤0.01%
17,333
– –
AVXL icon
2434
Anavex Life Sciences
AVXL
$323M
$178K ﹤0.01%
55,234
+1,086
+2% +$4.27K
ARAY icon
2435
Accuray
ARAY
$34.2M
$175K ﹤0.01%
40,617
-32,000
-44% -$147K
GNC
2436
DELISTED
GNC Holdings, Inc.
GNC
$173K ﹤0.01%
46,753
+25,700
+122% +$162K
INOV
2437
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$172K ﹤0.01%
11,476
-5,100
-31% -$81.1K
EGHT icon
2438
8x8 Inc
EGHT
$296M
$170K ﹤0.01%
+12,060
New +$167K
AMKR icon
2439
Amkor Technology
AMKR
$14B
$166K ﹤0.01%
16,516
+180
+1% +$1.93K
CASI
2440
DELISTED
CASI Pharmaceuticals
CASI
$164K ﹤0.01%
+5,040
New +$137K
CBK
2441
DELISTED
Christopher & Banks Corporation
CBK
$164K ﹤0.01%
128,942
-35,080
-21% -$44.4K
FRAN
2442
DELISTED
Francesca's Holdings Corporation
FRAN
$163K ﹤0.01%
1,856
– –
AREX
2443
DELISTED
Approach Resources Inc.
AREX
$163K ﹤0.01%
55,021
– –
ADXS
2444
DELISTED
Advaxis Inc
ADXS
$162K ﹤0.01%
3,807
+787
+26% +$39.8K
IMNN icon
2445
Imunon
IMNN
$6.89M
$161K ﹤0.01%
+308
New +$175K
VIVO
2446
DELISTED
Meridian Bioscience Inc
VIVO
$161K ﹤0.01%
+11,491
New +$168K
ONCS
2447
DELISTED
OncoSec Medical Incorporated
ONCS
$158K ﹤0.01%
+441
New +$154K
FMSA
2448
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$158K ﹤0.01%
30,235
+16,500
+120% +$77.7K
IDT icon
2449
IDT Corp
IDT
$1.62B
$157K ﹤0.01%
17,485
– –
RDNT icon
2450
RadNet
RDNT
$6.01B
$157K ﹤0.01%
15,500
-16,500
-52% -$172K
96 97
98
99 100

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.